PubMed:33177326
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T1 | 335-339 | Body_part | denotes | face | http://purl.org/sig/ont/fma/fma24728 |
| T2 | 343-347 | Body_part | denotes | face | http://purl.org/sig/ont/fma/fma24728 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 335-339 | Body_part | denotes | face | http://purl.obolibrary.org/obo/UBERON_0001456 |
| T2 | 343-347 | Body_part | denotes | face | http://purl.obolibrary.org/obo/UBERON_0001456 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 59-67 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T2 | 101-109 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T3 | 821-830 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
| T4 | 920-930 | Disease | denotes | infections | http://purl.obolibrary.org/obo/MONDO_0005550 |
| T5 | 1098-1107 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
| T6 | 1433-1442 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
| T7 | 1669-1678 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
| T8 | 1724-1731 | Disease | denotes | anxiety | http://purl.obolibrary.org/obo/MONDO_0005618|http://purl.obolibrary.org/obo/MONDO_0011918 |
| T10 | 1874-1883 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
| T11 | 1964-1971 | Disease | denotes | anxiety | http://purl.obolibrary.org/obo/MONDO_0005618|http://purl.obolibrary.org/obo/MONDO_0011918 |
| T13 | 2070-2078 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 122-123 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T2 | 179-182 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T3 | 230-233 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T4 | 335-339 | http://purl.obolibrary.org/obo/UBERON_0001456 | denotes | face |
| T5 | 343-347 | http://purl.obolibrary.org/obo/UBERON_0001456 | denotes | face |
| T6 | 438-439 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
| T7 | 1204-1205 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T8 | 1231-1233 | http://purl.obolibrary.org/obo/CLO_0053733 | denotes | 11 |
| T9 | 1250-1251 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T10 | 1509-1511 | http://purl.obolibrary.org/obo/CLO_0008882 | denotes | Rs |
| T11 | 1598-1600 | http://purl.obolibrary.org/obo/CLO_0008882 | denotes | Rs |
| T12 | 1773-1774 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T1 | 207-215 | Chemical | denotes | medicine | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T2 | 1998-2006 | Chemical | denotes | medicine | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T3 | 2028-2036 | Chemical | denotes | medicine | http://purl.obolibrary.org/obo/CHEBI_23888 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 11-15 | Phenotype | denotes | Pain | http://purl.obolibrary.org/obo/HP_0012531 |
| T2 | 243-247 | Phenotype | denotes | pain | http://purl.obolibrary.org/obo/HP_0012531 |
| T3 | 667-671 | Phenotype | denotes | Pain | http://purl.obolibrary.org/obo/HP_0012531 |
| T4 | 1409-1413 | Phenotype | denotes | pain | http://purl.obolibrary.org/obo/HP_0012531 |
| T5 | 1586-1590 | Phenotype | denotes | pain | http://purl.obolibrary.org/obo/HP_0012531 |
| T6 | 1724-1731 | Phenotype | denotes | anxiety | http://purl.obolibrary.org/obo/HP_0000739 |
| T7 | 1964-1971 | Phenotype | denotes | anxiety | http://purl.obolibrary.org/obo/HP_0000739 |
| T8 | 2023-2027 | Phenotype | denotes | pain | http://purl.obolibrary.org/obo/HP_0012531 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 2 | 11-15 | Disease | denotes | Pain | MESH:D010146 |
| 3 | 59-67 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 20 | 101-109 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 21 | 243-247 | Disease | denotes | pain | MESH:D010146 |
| 22 | 572-577 | Disease | denotes | COVID | MESH:C000657245 |
| 23 | 667-671 | Disease | denotes | Pain | MESH:D010146 |
| 24 | 815-830 | Disease | denotes | COVID infection | MESH:C000657245 |
| 25 | 920-930 | Disease | denotes | infections | MESH:D007239 |
| 26 | 1098-1107 | Disease | denotes | infection | MESH:D007239 |
| 27 | 1409-1413 | Disease | denotes | pain | MESH:D010146 |
| 28 | 1433-1442 | Disease | denotes | infection | MESH:D007239 |
| 29 | 1586-1590 | Disease | denotes | pain | MESH:D010146 |
| 30 | 1669-1678 | Disease | denotes | infection | MESH:D007239 |
| 31 | 1724-1731 | Disease | denotes | anxiety | MESH:D001007 |
| 32 | 1874-1883 | Disease | denotes | infection | MESH:D007239 |
| 33 | 1964-1971 | Disease | denotes | anxiety | MESH:D001007 |
| 34 | 2023-2027 | Disease | denotes | pain | MESH:D010146 |
| 35 | 2070-2078 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid_AGAC_only
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| p290053s9 | 1206-1215 | NegReg | denotes | decreased |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-68 | Sentence | denotes | Changes in Pain Medicine Training Programs Associated with COVID-19: |
| T2 | 69-84 | Sentence | denotes | Survey Results. |
| T3 | 85-96 | Sentence | denotes | BACKGROUND: |
| T4 | 97-216 | Sentence | denotes | The COVID-19 pandemic is a public health crisis of unprecedented proportions that has altered the practice of medicine. |
| T5 | 217-369 | Sentence | denotes | The pandemic has required pain clinics to transition in-person visits to telemedicine, postpone procedures and cancel face-to-face educational sessions. |
| T6 | 370-428 | Sentence | denotes | There are no data on how fellowship programs have adapted. |
| T7 | 429-437 | Sentence | denotes | METHODS: |
| T8 | 438-587 | Sentence | denotes | A 17-question survey was developed covering topics including changes in education, clinical care, and psychological stress due to the COVID pandemic. |
| T9 | 588-761 | Sentence | denotes | The survey was hosted by Qualtrics Inc. and disseminated by the Association of Pain Program Directors on April 10, 2020 to program directors at ACGME-accredited fellowships. |
| T10 | 762-948 | Sentence | denotes | Results are reported descriptively and stratified by COVID infection rate, which was calculated from Centers for Disease Control and Prevention data on state infections, and census data. |
| T11 | 949-957 | Sentence | denotes | RESULTS: |
| T12 | 958-1017 | Sentence | denotes | Among 107 surveys distributed, 70 (65%) programs responded. |
| T13 | 1018-1168 | Sentence | denotes | Twenty-nine programs were located in states in the upper tertile for per capita infection rates, 17 in the middle third, and 23 in the lowest tertile. |
| T14 | 1169-1302 | Sentence | denotes | Nearly all programs (93%) reported a decreased workload, with 11 (16%) reporting a dramatic decrease (only urgent or emergent cases). |
| T15 | 1303-1419 | Sentence | denotes | Just over half of programs had either already deployed (14%) or credentialed (39%) fellows to provide non-pain care. |
| T16 | 1420-1640 | Sentence | denotes | Higher state infection rates were significantly associated with reduced clinical demand (Rs = 0.31, 95% CI [0.08, 0.51], P = .011) and redeployment of fellows to non-pain areas (Rs = 0.30, 95% CI [0.07, 0.50], P = .013). |
| T17 | 1641-1750 | Sentence | denotes | Larger program size but not infection rate was associated with increased perceived anxiety level of trainees. |
| T18 | 1751-1763 | Sentence | denotes | CONCLUSIONS: |
| T19 | 1764-1979 | Sentence | denotes | We found a shift to online alternatives for clinical care and education, with correlations between per capita infection rates, and clinical care demands and redeployment, but not with overall trainee anxiety levels. |
| T20 | 1980-2189 | Sentence | denotes | It is likely that medicine in general, and pain medicine in particular, will change after COVID-19, with greater emphasis on telemedicine, virtual education, and greater national and international cooperation. |
| T21 | 2190-2238 | Sentence | denotes | Physicians should be prepared for these changes. |